EVALUATING THE CARDIOVASCULAR BENEFITS OF INNOVATOR SEMAGLUTIDE 2.4 MG (RECOMBINANT DNA (R-DNA)) IN PATIENTS WITH OVERWEIGHT OR OBESITY: A CRITICAL REVIEW OF CURRENT EVIDENCE

Descargar Publicación
GLP-1 therapies for obesity: mechanisms, outcomes, and regulatory challenges Ketogenic Diet in Obesity and Diabetes: A Narrative Review